Home
Conditions
Non-Hodgkin Lymphoma

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

219 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Recruiting

Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

NCT05583071

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Klinikum Stuttgart - Katharienenhospital Stuttgart, Baden-Wurttemberg, Germany

Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Würtemberg, Germany

University of Cologne Cologne, Germany

Universitätsklinikum Hamburg-Eppendorf Hamburg, Hamurg, Germany

View Trial Details

Recruiting

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

NCT02393157

Conditions: Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details

Recruiting

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

NCT04099966

Conditions: Acute Leukemia, Amegakaryocytic Thrombocytopenia, Anemia, +34 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT06343311

Conditions: B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
Locations: University of California, Davis Sacramento, California, United States

Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States

View Trial Details

Recruiting

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

NCT05253495

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: University of Alabama Birmingham, Alabama, United States

University of Flordia Gainsville, Florida, United States

New York Medical College Vallhala, New York, United States

View Trial Details

Recruiting

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT06323525

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China

Biotherapeutic Department of Chinese PLA General Hospital Beijing, China

School of Life Sciences, Peking University Beijing, China

View Trial Details

Recruiting

PTCy and ATG for MSD and MUD Transplants

NCT06299462

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +20 more
Locations: Instituto Nacional de Cancer Rio de Janeiro, Brazil

View Trial Details

Recruiting

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

NCT06479356

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Vitamin A and D Supplementation in Allogeneic HCT

NCT06508099

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +28 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Recruiting

Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients

NCT05921812

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Sohag University Sohag, Egypt

View Trial Details

Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma trial results

Related conditions